Amino Acids China E-News (Chinese version)

Publication: Monthly on the
Published by CCM

Amino Acids E-News (Chinese version)


  • Future-issues subscription

Starting from the issue of
201910
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.

<<
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201704
  • 201703
  • 201702
  • 201701
  • 201701
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
>>

Main Content of Amino Acids China E-News 201704(Chinese version)

Price of this issue :
USD 98

Published on 28th April, 2017

中国淀粉2016年在玉米价格下滑等因素影响下毛利大增,而发酵及下游产品收入比重增大。虽然相关产品价格有所下滑,但收入依然增长。赖氨酸业务表现较好,销量增长超过58%。

Published on 28th April, 2017

Published on 28th April, 2017

在春节过后的第一季度,受禽流感病毒和养殖需求降低的影响,国内苏氨酸市场弱势运行。而在即将到来的第二季度,随着养殖需求提升,原料价格有望回落,国内苏氨酸市场有望回暖。

Published on 28th April, 2017

2016年永安药业营业收入同比下降1.17%,净利润同比增长了253.71%。净利润大幅度增长主要得益于牛磺酸业务,由于需求不断增长,牛磺酸有望在可预见的将来继续成为公司的主要利润来源。

Published on 28th April, 2017

受到2016年蛋氨酸价格大幅下滑的影响,蓝星安迪苏全年营业收入和净利润均出现下滑。然而,维生素A价格的上涨和新产品的推出对业绩有一定的支撑。

Published on 28th April, 2017

2016年大成生化亏损持续,亏损主要是收款减少等因素导致,主营业务已经转亏为盈,特别是氨基酸业务利润大增。2017年得益于玉米低价,大成生化有望获得盈利。

Published on 28th April, 2017

2016年新和成的主营产品维生素A、维生素E、香精香料等价格上升幅度较大,因而公司的营业收入和净利润均出现上涨。同时蛋氨酸项目进展顺利,有望进一步增加新和成的收入。

Published on 28th April, 2017

由于供求关系失衡,2017年第一季度我国蛋氨酸市场整体处于低位徘徊的状态。

Published on 28th April, 2017

在4月玉米价格上涨、出口较好的情况下,持续下跌的国内赖氨酸价格呈现上涨趋势。但下游需求疲软,若无进一步利多因素出现,赖氨酸市场风险犹存。

Published on 28th April, 2017

2017年1~2月中国蛋氨酸进口量环比下跌但同比大增,这与进口价格大幅走低不无关系。在进口来源国上新加坡的地位越发提高,而生产企业赢创的占比也越来越大。

Published on 28th April, 2017

Published on 28th April, 2017

Published on 28th April, 2017

Published on 28th April, 2017

Published on 28th April, 2017

Published on 28th April, 2017

Published on 28th April, 2017

2016年,溢多利营业收入和净利润均有大幅度增长。目前公司的产品多涉及抗生素替代与新型酶制剂,在无抗饲料成为行业趋势的情况下,溢多利的发展有望进一步提高。

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement